Publications by authors named "Alvisi M"

Standard therapy for high-grade ovarian carcinoma includes surgery followed by platinum-based chemotherapy and poly-ADP ribose polymerase inhibitors (PARPis). Deficiency in homologous recombination repair (HRD) characterizes almost half of high-grade ovarian carcinomas and is due to genetic and epigenetic alterations in genes involved in HR repair, mainly and predicts response to PARPi. The academic and commercial tests set up to define the HRD status of the tumor rely on DNA sequencing analysis, while functional tests such as the RAD51 foci assay are currently under study, but have not been validated yet and are available for patients.

View Article and Find Full Text PDF

Background: Thymic carcinoma (TC) is a rare tumor with aggressive behavior. Chemotherapy with carboplatin plus paclitaxel represents the treatment of choice for advanced disease. Antiangiogenic drugs, including ramucirumab, have shown activity in previously treated patients.

View Article and Find Full Text PDF

To evaluate the rate of early breast cancer (EBC) patients treated with neoadjuvant systemic therapy (NAT) in Italy, criteria of patient selection and types of therapies delivered, an analysis of 1276 patients with stage I-II-III was conducted out of 1633 patients enrolled in the multicenter prospective observational BRIDE study. A total of 177 patients (13.9%) were treated with NAT and 1099 (85.

View Article and Find Full Text PDF

The role of moderate alcohol consumption in the evolution of NAFLD is still debated. The aim of this study is to evaluate the impact of current and lifelong alcohol consumption in patients with NAFLD. From 2015 to 2020, we enrolled 276 consecutive patients fulfilling criteria of NAFLD (alcohol consumption up to 140 g/week for women and 210 g/week for men).

View Article and Find Full Text PDF
Article Synopsis
  • Previous research indicated that combining cediranib with olaparib improved progression-free survival (PFS) in women with recurrent platinum-sensitive ovarian cancer compared to olaparib alone.
  • The BAROCCO trial involved 123 patients and compared the effects of paclitaxel, olaparib, and cediranib on PFS, revealing that the continuous schedule of cediranib-olaparib had a median PFS of 5.6 months, while paclitaxel had 3.1 months.
  • The results showed that the combination wasn’t superior to chemotherapy, but it may provide a viable non-chemotherapy option for patients with advanced and heavily pretreated ovarian cancer.
View Article and Find Full Text PDF

Introduction: Lung ultrasound (LUS) has become the first diagnostic imaging approach to assess lung involvement in COVID-19. While LUS proved to be safe, reliable, and accurate, not many primary care physicians (PCP) are capable to employ this instrument in the first evaluation of COVID-19 outpatients. The aim of this study was to determine the effectiveness of a brief training program in LUS for PCP.

View Article and Find Full Text PDF

High concentrations of ivermectin demonstrated antiviral activity against SARS-CoV-2 in vitro. The aim of this study was to assess the safety and efficacy of high-dose ivermectin in reducing viral load in individuals with early SARS-CoV-2 infection. This was a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial.

View Article and Find Full Text PDF

Background: The search for biomarkers to evaluate ovarian cancer (OC) homologous recombination (HR) function and predict the response to therapy is an urgent clinical need to improve the selection of patients who could benefit from platinum- and olaparib (poly-ADP ribose polymerase inhibitors, PARPi)-based therapies.

Methods: We used a large collection of OC patient-derived xenografts (PDXs) (n = 47) and evaluated their HR status based on BRCA1/2 mutations, BRCA1 promoter methylation and the HRDetect score. RAD51 foci were quantified in formalin-fixed, paraffin-embedded untreated tumour specimens by immunofluorescence and the messenger RNA expression of 21 DNA repair genes by real-time PCR.

View Article and Find Full Text PDF

Background: Platinum-based therapy, combined or not with immune checkpoint inhibitors, represents a front-line choice for patients with non-small-cell lung cancer (NSCLC). Despite the improved outcomes in the last years for this malignancy, only a sub-group of patients have long-term benefit. Excision repair cross-complementation group 1 (ERCC1) has been considered a potential biomarker to predict the outcome of platinum-based chemotherapy in NSCLC.

View Article and Find Full Text PDF

Background: Lung ultrasound (LU) is becoming an increasingly important diagnostic tool in detecting lung involvement in Corona Virus Disease 2019 (COVID-19). The aim of this study was to ascertain the likelihood of finding LU abnormalities; mimicking lung involvement; in COVID-19 negative healthy individuals.

Methods: We performed LU on 265 healthcare workers; not presenting COVID-19 major symptoms and in good health; during the course of a serological screening program for COVID-19 in our General Hospital.

View Article and Find Full Text PDF

Background: The psychological burden possibly deriving from not immediately undergoing radical treatment for prostate cancer (PCa) could be a potential disadvantage of active surveillance (AS), especially in the eve of some relevant clinical exams [i.e., re-biopsy, prostate-specific antigen (PSA) test, and medical examination].

View Article and Find Full Text PDF

Platinum resistance is an unmet medical need in ovarian carcinoma. Molecular biomarkers to predict the response to platinum-based therapy could allow patient stratification and alternative therapeutic strategies early in clinical management. Sensitivity and resistance to platinum therapy are partially determined by the tumor's intrinsic DNA repair activities, including nucleotide excision repair (NER) and base excision repair (BER).

View Article and Find Full Text PDF

Clinical data suggest that only a subgroup of non-small cell lung cancer (NSCLC) patients has long-term benefits after front-line platinum-based therapy. We prospectively investigate whether KRAS status and DNA polymerase β expression could help identify patients responding to platinum compounds. Prospectively enrolled, advanced NSCLC patients treated with a first-line regimen containing platinum were genotyped for KRAS and centrally evaluated for DNA polymerase β expression.

View Article and Find Full Text PDF

Objective: To investigate whether prostate cancer (PCa) patients' coping strategies (i.e., fighting spirit, anxious preoccupation, fatalism, helplessness/hopelessness, and avoidance) significantly change during the first 3-year follow-up period of active surveillance (AS).

View Article and Find Full Text PDF

The clinical usefulness of pancreatic elastography (PE) in the assessment of the pancreatic texture before pancreatic resection still remains uncertain. The aims are: to evaluate the value of pancreatic stiffness in both healthy volunteers and patients affected by pancreatic tumor; to evaluate the ability of PE in predicting clinically relevant postoperative pancreatic fistula (CR-POPF). Pancreatic stiffness of healthy subjects was compared with those of pancreatic tumors measuring shear wave velocity (SWV).

View Article and Find Full Text PDF

Background And Aims: Vedolizumab [VDZ] is a monoclonal antibody directed against the α4β7 integrin heterodimer, approved for patients with inflammatory bowel diseases [IBD]. This study aimed at identifying immunological variables associated with response to vedolizumab in patients with ulcerative colitis [UC] and Crohn's disease [CD].

Methods: This is a phase IV explorative prospective interventional trial.

View Article and Find Full Text PDF

Hepatic epithelioid hemangioendothelioma (HEHE) and fibrolamellar hepatocellular carcinoma (HCC) are rare malignant neoplasms of the liver. Contrarily to HCC, no distinctive imaging criteria based on contrast enhancement pattern are known for these neoplasms, thus they are frequently misdiagnosed as other liver tumors. Due to their infrequency, very few data principally based on reports of few patients are currently available in literature.

View Article and Find Full Text PDF

Purpose: To evaluate the outcomes of active surveillance (AS) on patients with low-risk prostate cancer (PCa) and to identify predictors of disease reclassification.

Methods: In 2005, we defined an institutional AS protocol (Sorveglianza Attiva Istituto Nazionale Tumori [SAINT]), and we joined the Prostate Cancer Research International: Active Surveillance (PRIAS) study in 2007. Eligibility criteria included clinical stage ≤T2a, initial prostate-specific antigen (PSA) <10 ng/mL, and Gleason Pattern Score (GPS) ≤3 + 3 (both protocols); ≤25% positive cores with a maximum core length containing cancer ≤50% (SAINT); and ≤2 positive cores and PSA density <0.

View Article and Find Full Text PDF

Purpose: The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) is a self-report questionnaire that was developed in English to assess prostate cancer (PCa)-related anxiety. The aim of this study was to perform a cultural adaptation for the tool to be used in a population of Italian men on active surveillance (AS).

Methods: A total of 222 patients with localized PCa who were recruited for the Prostate Cancer Research International: Active Surveillance (PRIAS) protocol completed the MAX-PC.

View Article and Find Full Text PDF

Multiwalled carbon nanotube (MWCNT)-based chemiresistors were electrochemically decorated with Au and Pd nanoparticles (NPs), resulting in an improvement in the detection of gaseous pollutants as compared to sensors based on pristine MWCNTs. Electrophoresis was used to decorate MWCNTs with preformed Au or Pd NPs, thus preserving their nanometer-sized dimensions and allowing the metal content to be tuned by simply varying the deposition time. The sensing response of unmodified and metal-decorated MWCNTs was evaluated towards different gaseous pollutants (e.

View Article and Find Full Text PDF

Pristine and electrochemically Pd-modified ZnO nanorods (ZnO NRs) were proposed as active sensing layers in chemiresistive gas sensors for hydrocarbon (HC) gas detection (e.g., CH, CH CH).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore whether patients experience regret after stopping an active surveillance (AS) protocol for cancer treatment and to identify potential influencing factors.
  • A total of 204 patients who had discontinued AS were asked to complete various questionnaires regarding their experiences, with 105 patients participating in the study.
  • The findings revealed that most participants reported low levels of regret about their decision to follow or discontinue the AS protocol, with no significant correlation identified between regret and sociodemographic or clinical variables.
View Article and Find Full Text PDF

A one-step electrochemical method based on sacrificial anode electrolysis (SAE) was used to deposit stabilized gold nanoparticles (Au NPs) directly on the surface of nanostructured ZnO powders, previously synthesized through a sol-gel process. The effect of thermal annealing temperatures (300 and 550 °C) on chemical, morphological, and structural properties of pristine and Au-doped ZnO nancomposites (Au@ZnO) was investigated. Transmission and scanning electron microscopy (TEM and SEM), as well as X-ray photoelectron spectroscopy (XPS), revealed the successful deposition of nanoscale gold on the surface of spherical and rod-like ZnO nanostructures, obtained after annealing at 300 and 550 °C, respectively.

View Article and Find Full Text PDF